Determination of azidothymidine and its degradation product thymine in pharmaceutical dosage forms by HPLC and HPTLC densitometry

[1]  H. Langtry,et al.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. , 1989, Drugs.

[2]  J. Beijnen,et al.  A rapid, simple and accurate method for the bioanalysis of zidovudine , 1989 .

[3]  P. Cload.  A review of the pharmacokinetics of zidovudine in man. , 1989, The Journal of infection.

[4]  P. Williams,et al.  Zidovudine--the first year of experience. , 1989, The Journal of infection.

[5]  J. Yeo.  Current and future trials with zidovudine. , 1989, The Journal of infection.

[6]  R. L. Johnson,et al.  The sexual behavior of adolescents and risk of AIDS. , 1988, JAMA.

[7]  A. Nitenberg,et al.  Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. , 1988, The American journal of medicine.

[8]  R. Sawchuk,et al.  A sensitive liquid-chromatographic method for determination of 3'-azido-3'-deoxythymidine (AZT) in plasma and urine. , 1988, Clinical chemistry.

[9]  H. Issaq,et al.  High-performance liquid chromatographic determination of 2',3'-dideoxycytidine and 3'-azido-3'-deoxythymidine in plasma using a column-switching technique. , 1988, Journal of chromatography.

[10]  J. Unadkat,et al.  Simple and rapid high-performance liquid chromatographic assay for zidovudine (azidothymidine) in plasma and urine. , 1988, Journal of chromatography.

[11]  D. Reynolds,et al.  Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatography. , 1988, Journal of chromatography.

[12]  D W Barry,et al.  3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R D Yee,et al.  Acquired immune deficiency syndrome. Ocular manifestations. , 1983, Ophthalmology.

[14]  J. Horwitz,et al.  Nucleosides. V. The Monomesylates of 1-(2'-Deoxy-β-D-lyxofuranosyl)thymine1,2 , 1964 .